Physician profile
Ram C Sharma
NPI 1447212964
$17,682.99
in general payments reported to CMS, 2019-2025
39 companies · $527 in 2025
The $527 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,985 · 2020: $5,855 · 2021: $5,302 · 2022: $1,249 · 2023: $966 · 2024: $798 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,134 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,133.78 |
| Education | $157.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $9,408.63 | 2020-2023 | Nexletol |
| Cardiovascular Systems INC. | $1,400.73 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $1,114.63 | 2019-2025 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $902.67 | 2019-2024 | Farxiga, Brilinta |
| Asahi Intecc USA, INC. | $756.34 | 2019 | |
| Amgen INC. | $649.35 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $448.55 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $387.07 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $372.77 | 2022-2025 | Verquvo, Winrevair |
| Novartis Pharmaceuticals Corporation | $324.99 | 2019-2024 | |
| Abbott Laboratories | $251.73 | 2022-2025 | Perclose Prostyle, Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Peripheral |
| Shockwave Medical, INC | $222.64 | 2022-2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $189.29 | 2019-2025 | Lifevest |
| Amarin Pharma, INC. | $131.72 | 2019-2020 | |
| Teleflex LLC | $129.66 | 2023 | Trapliner |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ram Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.